Last Updated on June 15, 2015
Advancing Biomarkers to Screen and Diagnose Preeclampsia: A Report to Stakeholders
In December 2012, the Preeclampsia Foundation convened stakeholders from industry, academia, FDA, laboratories, patients and clinicians to assess the state of biomarkers for preeclampsia, identify barriers and brainstorm strategies to overcome those challenges. This report includes background on the state of molecular biomarkers for preeclampsia screening and diagnosis, identification of the needs and challenges facing the field, the proceedings and participants of the Biomarkers Consortium, and the resulting calls to action, broken out by stakeholders (research and academia, manufacturers and laboratories, clinical, regulatory, and patient organizations).
Read the complete report of the first Biomarkers Consortium.
Related Articles
Congratulations on receiving your brand new Cuff Kit®! Want to learn more about how to use your iHealth Track device? Here are some handy videos and links to get you started. Unpacking and using...
Nurses play a vital role in detecting preeclampsia and caring for patient before, during, and beyond pregnancy.
A key component needed in the fight against preeclampsia is the development of tests for simple, rapid, and accurate diagnosis and prediction through the development and adoption of biomarkers.
As a first step to address the need for self-monitored blood pressure, the Preeclampsia Foundation started providing the Cuff Kit® in June 2020 to women at highest risk of developing preeclampsia and...
Every woman should be able to check her own blood pressure at home.
For more on the Preeclampsia Foundation's work to amplify all research related to biomarkers for improved prediction and diagnostic tools, please visit https://preeclampsia.org/biomarkers. INDIANAPOL...
GAP—SPIRIN campaign gets low-dose aspirin to those most at risk to help close the maternal health gap in preeclampsia ________ NEW YORK, January 23, 2025/PRNewswire/ – In recognition of...
1732072344.png)
While the Preeclampsia Foundation has been championing patient advocacy and representation for all families affected by hypertension in pregnancy throughout our 25 year history, we recognized the uniq...
Washington, DC – April 11, 2024 – On April 10, one day before the start of Black Maternal Health Week, the Preeclampsia Foundation in partnership with Thermo Fisher Diagnostics held a Hill...
Recently, I came across a social media post calling attention to the global maternal health crisis from a Black woman’s perspective. Someone responded to the post asking, “What’s rac...